期刊文献+

益气化瘀解毒方含药血清对鸡胚尿囊膜血管生成的影响 被引量:9

Study on Influence of Prescription of Strengthening Qi and Resolving Stasis and Eliminating Toxin on Serum Chicken Embryos Allantoic Membrane Angiogenesis
在线阅读 下载PDF
导出
摘要 目的:探讨益气化瘀解毒含药血清对鸡胚尿囊膜血管生成的影响。方法:取孵育7 d的种蛋制成CAM模型,加入益气化瘀解毒整方高、中、低3个剂量组的含药血清,继续孵育3 d,固定标本,拍熙,计数新生毛细血管数目。结果:高、中、低剂量组与不合药血清组比较,差异均有统计学意义(P<0.05);高、中剂量组与低剂量组比较,差异均有统计学意义(P<0.05);高、中剂量组间比较,差异无统计学意义(P>0.05)结论:益气化瘀解毒方能抑制CAM血管新生,具有抗血管生成作用。 Objective:To study the influence of prescription of strengthening Qi and resolving stasis and eliminating toxin on serum chicken embryos allantoic membrane angiogenesis.Methods:Eggs incubated for 7d were made into CAM model Joined high,medium and low doses of the serum containing medicine,and they were continuely to incubate for 3d. The specimens were fixed,took pictures,and the number of new blood capillary was counted.Results:The high,medium and low dose groups and no medicine group comparison differences were statistically significant(P0.05).High,medium and low dose groups comparison were statistically significant(P0.05).High,medium between dose groups comparison had no significant difference(P0.05).Conclusion:The prescription of strengthening Qi and resolving stasis and eliminating toxin can inhibit CAM angiogenesis,and has the antiangiogenic effect.
出处 《中华中医药学刊》 CAS 2013年第1期19-20,I0002,共3页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81001522) 首届中国中西医结合学会-金港榄香烯中医药肿瘤研究基金资助项目(2010-F10)
关键词 益气化瘀解毒方 鸡胚尿囊膜 血管生成 prescription of strengthening Qi and resolving stasis and eliminating toxin chicken embryos allantoic membrane angiogenesis
作者简介 郜文辉(1977-),女,河南南阳人,讲师,博士研究生,研究方向:巾医药抗肿瘤药理。 通讯作者:曾普华(1976-),男,湖南长沙人,副主任医师,博士,研究方向:恶性肿瘤的中西医结合诊治。
  • 相关文献

参考文献3

二级参考文献21

共引文献77

同被引文献40

  • 1黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1514
  • 2潘敏求,孙兆泉,刘礼意,黎月恒,唐湘娟.肝癌治则机理实验研究[J].中国中西医结合外科杂志,1995,1(5):311-311. 被引量:13
  • 3金炜东,陈孝平,蔡红娇.重楼提取物对HepG2细胞的毒性作用[J].华中科技大学学报(医学版),2006,35(1):103-106. 被引量:36
  • 4赵静,黄江生,杨爱军,王晨昱,刘伟,李敏.肝细胞癌中血管生成拟态的三维细胞培养及组织学研究[J].癌症,2007,26(2):123-126. 被引量:24
  • 5Lirdprapamongkol K, Chiablaem K, Sila-Asna M, et al. Exploringstemness gene expression and vasculogenic mimicry capacity inwell-and poorly-differentiated hepatocellular carcinoma celllines[J]. Biochem Biophys Res Commun,2012,422(3):429-435.
  • 6Liu WB, Xu GL, Jia WD, et al. Prognostic significance andmechanisms of patterned matrix vasculogenic mimicry inhepatocellular carcinoma[J]. Med Oncol,2011,28(1):228-238.
  • 7Guzman G, Cotler SJ, Lin AY, et al. A pilot study of vasculogenicmimicry immunohistochemical expression in hepatocellularcarcinoma[J]. Arch Pathol Lab Med,2007,131(12):349-357.
  • 8Sun B, Zhang S, Zhang D, et al. Vasculogenic mimicry isassociated with high tumor grade, invasion and metastasis, andshort survival in patients with hepatocellular carcinoma[J].Oncol Rep,2006,16(4):693-698.
  • 9Liu W, Xu G, Ma J, et al. Osteopontin as a key mediator forvasculogenic mimicry in hepatocellular carcinoma[J]. Tohoku J ExpMed,2011,224(1):29-39.
  • 10Tao Sun, Bao-cun Sun, Xiu-lan Zhao. Promotion of tumor cellmetastasis and vasculogenic mimicry by way of transcriptioncoactivation by Bcl-2 and Twist1 : A study of hepatocellularcarcinoma[J]. Hepatology,2011,54(5):1690-1706.

引证文献9

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部